Timing of luekocyte filtration during cardiopulmonary bypass

Perfusion

Volumn 16, Issue SUPPL., 2001, Pages 31-37

  Matheis, G ^a   Scholz, M ^a   Simon, A ^a   Henrich, D ^a   Wimmer Greinecker, G ^a   Moritz, A ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; DOBUTAMINE;

AORTA CLAMPING; ARTERY; ARTICLE; ASSAY; BLOOD FILTER; BLOOD FILTRATION; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DOUBLE BLIND PROCEDURE; HEART MUSCLE INJURY; HEART MUSCLE REPERFUSION; HEART SURGERY; HUMAN; IN VITRO STUDY; LABORATORY TEST; LEUKOCYTE; PATHOGENICITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHORT COURSE THERAPY; TIME; TREATMENT OUTCOME; LEUKOCYTE FILTRATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPERFUSION; FILTRATION; LEUKAPHERESIS; METABOLISM; METHODOLOGY; NEUTROPHIL; PATHOLOGY; REVIEW; STANDARD;

CARDIOPULMONARY BYPASS; CLINICAL TRIALS; FILTRATION; HUMANS; LEUKAPHERESIS; NEUTROPHILS; TIME FACTORS;

EID: 0035045234     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1177/026765910101600i105     Document Type: Article

References (36)

1. Cardiopulmonary bypass-induced inflammation: Is it important?
2. Amplification of the inflammatory response: Adhesion molecules associated with platelet/white cell responses
3. Initiation of white cell activation during cardiopulmonary bypass: Cytokines and receptors
4. Complement and the damaging effects of cardiopulmonary bypass
5. Inflammatory response to cardiopulmonary bypass
6. Leukocyte depletion results in improved lung function and reduced inflammatory response after cardiac surgery
7. Leukocyte reduction in blood component therapy
8. Prevention of transfusion-associated cytomegalovirus infection in neonatal patients by the removal of white cells from blood
9. Prevention of reperfusion injury in the neonatal heart with leukocyte depleted blood
10. Leukocyte depletion ameliorates free radical-mediated lung injury after cardiopulmonary bypass
11. Temporary leukocyte depletion reduces ventricular dysfunction during prolonged postischemic reperfusion
12. Pall leukocyte depleting filter during cardiopulmonary bypass
13. Leukocyte depletion reduces postoperative oxygen requirements
14. Depletion of neutrophils by filter during aortocoronary bypass surgery transiently improves postoperative cardiorespiratory status
15. The influence of leukocyte filtration during cardiopulmonary bypass on postoperative lung function: A clinical study
16. Clinical performance of a high efficacy rapid flow leukocyte removal filter for leukocyte depletion of heparinized cardiopulmonary bypass perfusate
17. Biocompatibility of leukocyte removal filters during leukocyte filtration of cardiopulmonary bypass perfusate
18. The protective effect of a leucocyte removal filter on the lung in open-heart surgery for ventricular septal defect
19. Leukocyte depletion during cardiac operation: A new approach through the venous bypass circuit
20. Leukocyte filtration in the early reperfusion phase on cardiopulmonary bypass reduces myocardial injury
21. Clinical evaluation of a leucocyte-depleting blood cardioplegia filter (BC1B) for elective open-heart surgery
22. Studies of controlled reperfusion after ischemia. XXII. Reperfusate composition: Effects of leukocyte depletion of blood and blood cardioplegic reperfusates after acute coronary occlusion
23. Leukocyte depletion of blood cardioplegia attenuates reperfusion injury
24. Leucocyte filtration during cardiopulmonary reperfusion in coronary artery bypass surgery
25. Flow cytometric assays of oxidative burst activity in phagocytes
26. Update on leucocyte depletion of blood components by filtration
27. Modifying risk for extracorporeal circulation: Trial of four antiinflammatory strategies
28. Efficiency and safety of leukocyte filtration during cardiopulmonary bypass for cardiac surgery
29. Extracorporeal and intracorporeal filtration for CPB
30. Synthetic protein treated versus heparin coated cardiopulmonary bypass surfaces: Similar clinical results and minor biochemical differences
31. Cardiopulmonary bypass circuit treated with surface-modifying additives: A clinical evaluation of blood compatibility
32. Pulsatile reperfusion: The effects on coronary blood flow and myocardial ischemic injury
33. Oxygenated cardioplegia: Blood is a many splendored thing
34. Laboratory studies of the effect of Pall extracorporeal leucocyte filters LG6 and AV6 on patients undergoing coronary bypass grafts
35. Effects on complement, granulocytes and platelets of a leukocyte-depletion filter during in vitro extracorporeal circulation
36. Neutrophils delay functional recovery of the post-hypoxic heart of the rabbit